Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013 (2013), Article ID 821745, 7 pages
http://dx.doi.org/10.1155/2013/821745
Clinical Study

Comparison of Efficiencies of Michigan Neuropathy Screening Instrument, Neurothesiometer, and Electromyography for Diagnosis of Diabetic Neuropathy

1Ankara Numune Education and Research Hospital, Department of Endocrinology, Sıhhiye, 06622 Ankara, Turkey
2Duzce University, Faculty of Medicine, Endocrinology and Metabolism Department, Turkey
3Ankara Numune Research and Education Hospital, Department of Neurology, Turkey

Received 25 February 2013; Revised 21 April 2013; Accepted 22 April 2013

Academic Editor: Ilias Migdalis

Copyright © 2013 Turkan Mete et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Dyck, K. M. Kratz, J. L. Karnes et al., “The prevalance by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study,” Neurology, vol. 43, pp. 817–824, 1993. View at Google Scholar
  2. A. J. M. Boulton, A. I. Vinik, J. C. Arezzo et al., “Diabetic neuropathies: a statement by the American Diabetes Association,” Diabetes Care, vol. 28, no. 4, pp. 956–962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. England, G. S. Gronseth, G. Franklin et al., “Distal symmetrical polyneuropathy: definition for clinical research,” Muscle and Nerve, vol. 31, no. 1, pp. 113–123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. P. Wilkinson, F. L. Ferris, R. E. Klein et al., “Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales,” Ophthalmology, vol. 110, no. 9, pp. 1677–1682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “CKD-EPI (chronic kidney disease epidemiology collaboration) a new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, pp. 604–612, 2009. View at Google Scholar
  6. E. L. Feldman, M. J. Stevens, P. K. Thomas, M. B. Brown, N. Canal, and D. A. Greene, “A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy,” Diabetes Care, vol. 17, no. 11, pp. 1281–1289, 1994. View at Google Scholar · View at Scopus
  7. D. Yarnitsky and E. Sprecher, “Thermal testing: normative data and repeatability for various test algorithms,” Journal of the Neurological Sciences, vol. 125, no. 1, pp. 39–45, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Kocer, G. Sucak, R. Kuruoglu, Z. Aki, R. Haznedar, and N. Ince Erdogmus, “Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy,” Acta Neurologica Belgica, vol. 109, no. 2, pp. 120–126, 2009. View at Google Scholar · View at Scopus
  9. C. Valeri, P. Pozzilli, and D. Leslie, “Glucose control in diabetes,” Diabetes/Metabolism Research and Reviews, vol. 20, supplement 2, pp. S1–S8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. J. Dyck, J. L. Davies, D. M. Wilson, F. J. Service, L. J. Melton, and P. C. O'Brien, “Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort,” Diabetes Care, vol. 22, no. 9, pp. 1479–1486, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. B. C. Callaghan, J. Hur, and E. L. Feldman, “Diabetic neuropathy: one disease or two?” Current Opinion in Neurology, vol. 25, pp. 536–541, 2012. View at Google Scholar
  12. S. Tesfaye, N. Chaturvedi, S. E. M. Eaton et al., “Vascular risk factors and diabetic neuropathy,” The New England Journal of Medicine, vol. 352, no. 4, pp. 341–431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Erbas, M. Ertas, A. Yucel, A. Keskinaslan, and M. Senocak, “Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients,” Journal of Clinical Neurophysiology, vol. 28, no. 1, pp. 51–55, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Arezzo, “Clinical features and treatments of diabetic neuropathy. Quantitative sensory testing,” in Textbook of Diabetic Neuropathy, A. F. Gries, N. E. Cameron, P. A. Low, and D. Ziegler, Eds., pp. 184–189, Thieme Publishing Group, Stuttgart, Germany, 2003. View at Google Scholar
  15. J. M. Miralles-García, P. de Pablos-Velasco, L. Cabrerizo, M. Pérez, V. López-Gómez, and Sociedad Española de Endocrinología y Nutrición, “Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years disease duration,” Endocrinología y Nutrición, vol. 57, pp. 414–420, 2010. View at Google Scholar
  16. J. C. Kincaid, K. L. Price, M. C. Jimenez, and V. Skljarevski, “Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes,” Muscle and Nerve, vol. 36, no. 6, pp. 821–827, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Bril, J. Kojic, M. Ngo, and K. Clark, “Comparison of a neurothesiometer and vibratron in measuring vibration perception thresholds and relationship to nerve conduction studies,” Diabetes Care, vol. 20, no. 9, pp. 1360–1362, 1997. View at Google Scholar · View at Scopus
  18. T. Kästenbauer, S. Sauseng, H. Brath, H. Abrahamian, and K. Irsigler, “The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer,” Diabetic Medicine, vol. 21, no. 6, pp. 563–567, 2004. View at Publisher · View at Google Scholar · View at Scopus